Default company panoramic image

Emerald Logic

Our FACET software accelerates drug development with rapid biomarker discovery, quantitative diagnostics, and clinical trial enhancement.

  • Stage Full Product Ready
  • Industry Software
  • Location Aliso Viejo, CA, USA
  • Currency USD
  • Founded March 2011
  • Employees 2
  • Website

Company Summary

Emerald Logic is a pioneer in quantitative personalized medicine and biomarker discovery. The company’s FACET (FAst Collective Evolution Technology) software combines principles and math from biology, engineering, and particle physics to answer intractable questions with high human and economic impact.


  • Default avatar
    Patrick Lilley

    CEO 2 startups, 1 sold to HP for $160M, 1 to European firm for 10X in 1 year. VP Operations of start-up Microsoft bought for $275M. Grew a U.S. wireless subsidiary from zero to $5.5M in 1 year to support IPO. Public company division turnaround (1 yr): revenue up 3X, pipeline 27X, costs cut 33%.

    Operations, marketing, business development, finance, product management, technology (9 patents).

    Global hyper-growth expert, from start-up to $4.5

  • Default avatar
    Patrick O'Neill

    CTO/founder of Digital Transit. Primary investor Nokia. Merged with Bitfone, sold to HP for $160M. CTO/founder of Deep Six Technologies. Sold to European firm in a year.

    Contract problem solver: language converters, mobile, machine vision, multimedia, gaming, finance.

    90+ patents filed (evolutionary computing, compression, large-scale systems, messaging security, etc.)

    Consumer & enterprise software, mobile, multiplayer gaming, online

  • Default avatar
    Milton Lohr

    Former Undersecretary of Defense for Acquisition, NATO acquisitions representative, entrepreneur, independent defense & space professional.

  • Default avatar
    Babak Hassibi

    Professor & Executive Officer of Electrical Engineering, Cal Tech; former Bell Labs Tech Staff.

  • Default avatar
    Ashwin Rangan

    CIO of Edwards Lifesciences, CIO of, CIO of Conexant, Consulting CIO to Bank of America.

  • Default avatar
    Kevin Horgan

    Seasoned physician scientist with executive leadership experience in development of large and small molecules across multiple therapeutic areas. Pediatric and orphan drug development expertise. Extensive regulatory agency interactions and presentations including FDA Advisory Committees.

    Clinical development of novel therapies and diagnostics, translational medicine, personalized medicine, risk management, bayesian thinking and "bi

Previous Investors

  • Default avatar
    Various angel investors (current seed round)